Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-08-15

FDA Approved: OXCARBAZEPINE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Oxcarbazepine by Breckenridge Pharmaceutical, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)